Uremic toxicity:: present state of the art

被引:218
作者
Vanholder, R
Argilés, A
Baurmeister, U
Brunet, P
Clark, W
Cohen, G
De Deyn, PP
Deppisch, R
Descamps-Latscha, B
Henle, T
Jörres, A
Massy, ZA
Rodriguez, M
Stegmayr, B
Stenvinkel, P
Wratten, ML
机构
[1] Ghent Univ Hosp, Dept Internal Med, Nephrol Sect, B-9000 Ghent, Belgium
[2] Inst Human Genet, IGH, CNRS, UPR 1142, Montpellier, France
[3] Membrana GmbH, Wuppertal, Germany
[4] Hop St Marguerite, Marseille, France
[5] Baxter Healthcare Corp, Lessines, Belgium
[6] Univ Vienna, Dept Med, Div Nephrol, Vienna, Austria
[7] Univ Antwerp, Middelheim Hosp, Dept Neurol, Lab Neurochem & Behav, Antwerp, Belgium
[8] Gambro Corp Res, Hechingen, Germany
[9] Hop Necker Enfants Malad, INSERM, U507, Paris, France
[10] Tech Univ Dresden, Inst Food Chem, D-8027 Dresden, Germany
[11] Humboldt Univ, Fac Med, UK Charite, Berlin, Germany
[12] Hop Necker Enfants Malad, INSERM, U507, Paris, France
[13] CH Beauvals, Div Nephrol, Paris, France
[14] Univ Hosp Reina Sofia, Res Inst, Cordoba, Spain
[15] Norrlands Univ Hosp, Med Clin, Umea, Sweden
[16] Huddinge Univ Hosp, Dept Nephrol, S-14186 Huddinge, Sweden
[17] Bellco SPA, Mirandola, Italy
关键词
uremia; uremic toxins; low molecular weight proteins; AGE; PTH; AOPP; protein bound uremic solutes; P-cresol; CMPF; removal strategies;
D O I
10.1177/039139880102401004
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The uremic syndrome is a complex mixture of organ dysfunctions, which is attributed to the retention of a myriad of compounds that under normal condition are excreted by the healthy kidneys (uremic toxins). In the area of identification and characterization of uremic toxins and in the knowledge of their pathophysiologic importance, major steps forward have been made during recent years. The present article is a review of several of these steps, especially in the area of information about the compounds that could play a role in the development of cardiovascular complications. It is written by those members of the Uremic Toxins Group, which has been created by the European Society for Artificial Organs (ESAO). Each of the 16 authors has written a state of the art in his/her major area of interest.
引用
收藏
页码:695 / 725
页数:31
相关论文
共 334 条
[1]  
Abreo K, 1997, J AM SOC NEPHROL, V8, P935
[2]  
AHMED MU, 1986, J BIOL CHEM, V261, P4889
[3]   EXCESS PARATHYROID-HORMONE ADVERSELY AFFECTS LIPID-METABOLISM IN CHRONIC-RENAL-FAILURE [J].
AKMAL, M ;
KASIM, SE ;
SOLIMAN, AR ;
MASSRY, SG .
KIDNEY INTERNATIONAL, 1990, 37 (03) :854-858
[4]   VERAPAMIL PREVENTS CHRONIC RENAL FAILURE-INDUCED ABNORMALITIES IN LIPID-METABOLISM [J].
AKMAL, M ;
PERKINS, S ;
KASIM, SE ;
OH, HY ;
SMOGORZEWSKI, M ;
MASSRY, SG .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 22 (01) :158-163
[5]   DIALYSIS MYELOPATHY - QUADRIPARESIS DUE TO EXTRADURAL AMYLOID OF BETA-2 MICROGLOBULIN ORIGIN [J].
ALLAIN, TJ ;
STEVENS, PE ;
BRIDGES, LR ;
PHILLIPS, ME .
BRITISH MEDICAL JOURNAL, 1988, 296 (6624) :752-753
[6]  
Almaden Y, 1996, J BONE MINER RES, V11, P970
[7]  
ALMARDINI H, 1979, INT J ARTIF ORGANS, V2, P290
[8]   INFLUENCE OF HYPERINSULINEMIA ON INTRACELLULAR AMINO-ACID LEVELS AND AMINO-ACID EXCHANGE ACROSS SPLANCHNIC AND LEG TISSUES IN UREMIA [J].
ALVESTRAND, A ;
DEFRONZO, RA ;
SMITH, D ;
WAHREN, J .
CLINICAL SCIENCE, 1988, 74 (02) :155-163
[9]   Hyperphosphataemia - a silent killer of patients with renal failure? [J].
Amann, K ;
Gross, ML ;
London, GM ;
Ritz, E .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (09) :2085-2087
[10]  
AOYAGI R, 1993, KIDNEY INT, V43, pS111